Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.52M Sell
42,935
-879
-2% -$103K 0.8% 24
2026
Q1
$5.27M Sell
43,814
-6,268
-13% -$724K 0.84% 22
2025
Q4
$5.27M Buy
50,082
+1,510
+3% +$142K 0.82% 25
2025
Q3
$4.08M Sell
48,572
-2,380
-5% -$196K 0.57% 37
2025
Q2
$4.03M Buy
50,952
+6,300
+14% +$501K 0.57% 32
2025
Q1
$4.01M Sell
44,652
-1,930
-4% -$180K 0.71% 28
2024
Q4
$4.63M Sell
46,582
-3,150
-6% -$325K 0.82% 23
2024
Q3
$5.65M Buy
49,732
+2,590
+5% +$308K 0.97% 18
2024
Q2
$5.84M Buy
47,142
+183
+0.4% +$23.6K 1.18% 15
2024
Q1
$6.2M Buy
46,959
+1,489
+3% +$184K 1.28% 13
2023
Q4
$4.96M Sell
45,470
-1,725
-4% -$179K 1.1% 17
2023
Q3
$4.86M Sell
47,195
-135
-0.3% -$14.6K 1.22% 15
2023
Q2
$5.46M Buy
47,330
+36
+0.1% +$4.09K 1.31% 11
2023
Q1
$5.03M Sell
47,294
-6,371
-12% -$688K 1.26% 11
2022
Q4
$5.95M Sell
53,665
-7,840
-13% -$801K 1.49% 11
2022
Q3
$5.3M Sell
61,505
-717
-1% -$64K 1.37% 13
2022
Q2
$5.67M Buy
62,222
+868
+1% +$77K 1.43% 10
2022
Q1
$5.03M Sell
61,354
-3,273
-5% -$258K 1.08% 13
2021
Q4
$4.95M Buy
64,627
+717
+1% +$57.1K 0.99% 17
2021
Q3
$4.8M Buy
63,910
+1,295
+2% +$98.5K 1.05% 15
2021
Q2
$4.87M Buy
62,615
+6,671
+12% +$496K 1.15% 12
2021
Q1
$4.12M Sell
55,944
-6,168
-10% -$455K 1.41% 15
2020
Q4
$4.85M Buy
62,112
+5,972
+11% +$457K 1.67% 6
2020
Q3
$4.44M Buy
56,140
+4,092
+8% +$321K 1.85% 7
2020
Q2
$3.84M Sell
52,048
-837
-2% -$63K 1.7% 9
2020
Q1
$3.88M Buy
52,885
+2,322
+5% +$182K 1.96% 8
2019
Q4
$4.39M Sell
50,563
-956
-2% -$78.5K 1.78% 10
2019
Q3
$4.14M Buy
51,519
+246
+0.5% +$19.7K 1.75% 10
2019
Q2
$4.1K Sell
51,273
-6,733
-12% -$516K 1.75% 9
2019
Q1
$4.6K Sell
58,006
-17,976
-24% -$1.34M 1.98% 7
2018
Q4
$5.54K Sell
75,982
-606
-0.8% -$42.8K 2.63% 6
2018
Q3
$5.18M Buy
76,588
+1,341
+2% +$85.4K 2.07% 9
2018
Q2
$4.36M Buy
75,247
+8,169
+12% +$461K 1.86% 10
2018
Q1
$3.49M Buy
67,078
+8,977
+15% +$485K 1.49% 14
2017
Q4
$3.12M Buy
58,101
+2,527
+5% +$140K 1.25% 25
2017
Q3
$3.4K Buy
55,574
+2,368
+4% +$144K 1.43% 16
2017
Q2
$3.25K Buy
53,206
+1,017
+2% +$61.9K 1.45% 19
2017
Q1
$3.16K Buy
52,189
+1,401
+3% +$85K 1.4% 18
2016
Q4
$2.85M Buy
50,788
+52
+0.1% +$3.04K 1.24% 20
2016
Q3
$3.02M Sell
50,736
-3,590
-7% -$210K 1.32% 19
2016
Q2
$2.99M Sell
54,326
-783
-1% -$41.7K 1.23% 24
2016
Q1
$2.78M Sell
55,109
-2,030
-4% -$99.4K 1.15% 25
2015
Q4
$2.88M Buy
57,139
+1,336
+2% +$67.4K 1.12% 25
2015
Q3
$2.63M Buy
55,803
+2,865
+5% +$152K 1.01% 29
2015
Q2
$2.88M Buy
52,938
+1,159
+2% +$65K 1.01% 31
2015
Q1
$2.84M Buy
+51,779
New +$2.93M 0.97% 33

Other funds holding MRK

Chicago Trust's MRK Position: Q2 2026 in Review

Chicago Trust reduced its Merck (MRK) stake by 2% in Q2 2026, selling an estimated $103K and leaving 42,935 shares worth $5.52M. The position accounts for 0.8% of the portfolio, ranked #24.

Chicago Trust first reported a position in MRK in Q1 2015 and has held it in 46 quarters since. The position peaked at $6.2M in Q1 2024. 810 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Chicago Trust held 42,935 shares of Merck worth $5.52M as of Q2 2026.
  • Chicago Trust sold 879 Merck shares in Q2 2026, an estimated $103K.
  • Merck made up 0.8% of Chicago Trust's portfolio in Q2 2026, its #24 holding.
  • Chicago Trust first reported a position in Merck in Q1 2015 and has held it in 46 quarters since.
  • Chicago Trust's Merck position peaked at $6.2M in Q1 2024.
  • 810 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.